Rchr
J-GLOBAL ID:202301005285630274
Update date: May. 14, 2024
Tanaka Noritaka
Tanaka Noritaka
Research theme for competitive and other funds (4):
- 2023 - 2025 KRAS阻害剤による低酸素応答のリプログラミングに関する解析
- 2019 - 2023 Elucidation of gene dependence of sarcoma cells using functional genomics approach
- 2016 - 2019 Synthetic lethality-based identification of drug-sensitive genome profiles
- 2016 - 2019 Screening of molecular target for cancer therapy by using chemical genetics and functional genomics
Papers (10):
-
Douglas A. Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S. Kapner, Michael H. Rosenthal, Bryanna L. Norden, Haley Barnes, Sara Ehnstrom, Alvin A. Morales-Giron, Lauren K. Brais, et al. Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers. Cancer Discovery. 2024
-
Noritaka Tanaka, Hikari Okada, Kiyoshi Yamaguchi, Masahide Seki, Daisuke Matsubara, Noriko Gotoh, Yutaka Suzuki, Yoichi Furukawa, Taro Yamashita, Jun-ichiro Inoue, et al. Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation. Cell Death and Disease. 2023. 14. 12
-
Noritaka Tanaka, Takeharu Sakamoto. MT1-MMP as a Key Regulator of Metastasis. Cells. 2023. 12. 17
-
Noritaka Tanaka, Takeharu Sakamoto. Mint3 as a Potential Target for Cooling Down HIF-1α-Mediated Inflammation and Cancer Aggressiveness. Biomedicines. 2023. 11. 2
-
Junichi Ikeda, Chisato Ohe, Noritaka Tanaka, Takashi Yoshida, Ryoichi Saito, Naho Atsumi, Takashi Kobayashi, Hidefumi Kinoshita, Koji Tsuta, Takeharu Sakamoto. Hypoxia inducible factor-1 activator munc-18-interacting protein 3 promotes tumour progression in urothelial carcinoma. Clinical and Translational Discovery. 2023. 3. 1
more...
Professional career (1):
- Ph.D., Pharmaceutical Science (Keio University)
Work history (4):
- 2024/04 - 現在 Aichi Cancer Center Research Institute Division of Molecular Therapeutics
- 2022/01 - 2024/03 Kansai Medical University, Institute of Biomedical Science Cancer Biology Assistant Professor
- 2019/09 - 2021/12 Massachusetts General Hospital Cancer Center Research Fellow
- 2017/04 - 2019/09 Japanese Foundation for Cancer Research, Molecular of Pharmacy Molecular Pharmacology Postdoc
Return to Previous Page